Thyroid Surgery Complication May Not Affect Quality of Life
METHODOLOGY:
Researchers in Sweden conducted a population-based retrospective cohort study to examine differences in health-related quality of life between patients with and without hypoparathyroidism who underwent total thyroidectomy for benign thyroid disease between 2005 and 2015.
They analysed data of 46 patients (mean age, 35.8 years) with permanent hypoparathyroidism and 653 patients (mean age, 45.7 years) without the condition.
Permanent hypoparathyroidism was defined as low serum levels of parathyroid hormone with hypocalcaemia at 12 months post-surgery or at least one failed attempt to manage levels of calcium and/or active vitamin D at 12-24 months post-surgery.
The quality of life was assessed using the Swedish version of the 36-item Short Form Health Survey questionnaire, evaluating eight health domains and two summary scores.
The mean follow-up duration of the study was 10.9 years.
TAKEAWAY:
No significant differences in baseline characteristics, including indication for surgery, were observed between patients with and without permanent hypoparathyroidism; however, those with permanent hypoparathyroidism were significantly younger than those without (mean age, 35.8 vs 45.7 years; P < .001).
< .001). Similarly, no significant differences were observed between patients with and without permanent hypoparathyroidism across all health domains and the summary component scores ( P > .05 for all).
> .05 for all). A comparable proportion of patients with and without permanent hypoparathyroidism scored within or above the average range on the physical component summary ( P = .802) and the mental component summary ( P = .387).
IN PRACTICE:
"It is possible that the impact on HRQoL [health-related quality of life] is most prominent during the initial interval and diminishes over time as patients adapt to their life-long complication," the authors wrote.
SOURCE:
This study was led by Matilda Annebäck, Uppsala University Hospital, Uppsala, Sweden. It was published online on May 07, 2025, in BJS Open .
LIMITATIONS:
This study did not include data on socioeconomic status, comorbidities, and thyroid-stimulating hormone levels. The response rate of the study was 48.3%, which could have introduced a non-response bias. The 36-item Short Form Health Survey questionnaire might not fully capture aspects unique to hypoparathyroidism.
DISCLOSURES:
This study was supported by grants from the Bergholm Foundation. The authors declared having no conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
UnitedHealth says it is under a federal investigation and cooperating
Shares of UnitedHealth Group slipped Thursday after the health care giant said it was under a Department of Justice investigation. The company said it has started complying with both criminal and civil requests from federal investigators and it was cooperating with them. '(UnitedHealth) has a long record of responsible conduct and effective compliance,' the company said in a Securities and Exchange Commission filing. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. UnitedHealth Group Inc. said in February that it wasn't aware of the start of any new activity as the paper reported. The company said Thursday that it reached out to the Justice Department 'after reviewing media reports about investigations into certain aspects of the company's participation in the Medicare program.' UnitedHealth runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. Company shares have mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. The stock price dropped 2%, or $6.13, to $286.50 Thursday morning. Tom Murphy, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Times
24 minutes ago
- New York Times
Is the Bread in Europe Better for You?
In a video on TikTok, Christian Collins unwraps a crusty baguette and addresses his five million followers. Why, he asks, can he eat 'pizza and full-on buns every day' in Europe, but bread in the United States and Canada causes issues? These can include an upset stomach, fatigue and a 'foggy head,' Mr. Collins said in an interview with The Times. Mr. Collins, who describes himself as a digital nomad, is just one of many people on various platforms who have, for years, talked about this puzzling phenomenon. In June, Joe Rogan amplified the idea that European bread products might be superior on his popular podcast. 'Go eat bread in Italy,' he said. 'You don't feel bad at all.' Dr. Alessio Fasano, a gastroenterologist at Mass General Brigham, said he had heard similar accounts from many of his patients with certain types of wheat sensitivities. When they eat wheat products in the United States, his patients say, they have bloating, nausea, diarrhea, constipation, joint pain, fatigue or brain fog. When they eat wheat products — particularly bread — in Western Europe, they have fewer or milder symptoms. There isn't solid research on why this may be, Dr. Fasano said. But he and other experts have some theories. Want all of The Times? Subscribe.
CBS News
24 minutes ago
- CBS News
UnitedHealth says it's under federal investigation for civil fraud
Shares of UnitedHealth Group slipped Thursday after the health care giant said it was under a Department of Justice investigation. The company said it has started complying with both criminal and civil requests from federal investigators and it was cooperating with them. "(UnitedHealth) has a long record of responsible conduct and effective compliance," the company said in a Securities and Exchange Commission filing. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. UnitedHealth Group Inc. said in February that it wasn't aware of the start of any new activity as the paper reported. The company said Thursday that it reached out to the Justice Department "after reviewing media reports about investigations into certain aspects of the company's participation in the Medicare program." UnitedHealth runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. Company shares have mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. The stock price was down 1.7%, or $4.97, to $287.54 Thursday morning.
